⌘K

Home/Filings/4/0001193125-25-280748

4//SEC Filing

Cheng Andrew 4

Accession 0001193125-25-280748

CIK 0001744659other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 8:03 PM ET

Size

4.7 KB

Accession

0001193125-25-280748

Insider Transaction Report

Form 4

Period: 2025-11-12

Akero Therapeutics, Inc.AKRO

DirectorPresident and CEO

Transactions

Gift
Common Stock
2025-11-12−14,739→ 511,375 total

Footnotes (1)

[F1]The reported transaction represents a bona fide charitable gift to a 501(c)(3) organization. The Reporting Person does not have any pecuniary interest in the 501(c)(3) organization.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Akero Therapeutics, Inc.

CIK 0001744659

Entity typeother

Related Parties

1

filerCIK 0001778307

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 8:03 PM ET
Size: 4.7 KB

View on SEC.gov